US OptionsDetailed Quotes
ULTA241213C455000
- 0.02
- -0.06-75.00%
15min DelayClose Dec 13 15:59 ET
0.02High0.02Low
0.02Open0.08Pre Close2 Volume297 Open Interest455.00Strike Price4.00Turnover1962.26%IV7.29%PremiumDec 13, 2024Expiry Date0.00Intrinsic Value100Multiplier-1DDays to Expiry0.02Extrinsic Value100Contract SizeAmericanOptions Type0.0054Delta0.0013Gamma21205.50Leverage Ratio-109.2347Theta0.0000Rho115.04Eff Leverage0.0001Vega
Ulta Beauty Stock Discussion
Sign in to post a comment
$Esperion Therapeutics (ESPR.US)$ $Esperion Therapeutics (ESPR.US)$ Esperion Therapeutics (ESPR) is a biotech company that focuses on developing and commercializing therapies to lower cholesterol, specifically offering the only FDA-approved statin alternatives: NEXLIZET and NEXLETOL for PRIMARY PREVENTION. These drugs are designed for individuals who are statin intolerant or cannot achieve adequate cholesterol lowering with statin...
+4
1
8
$Ulta Beauty (ULTA.US)$ all it does is fade all day. low volume fade. honestly what a scam.
$Ulta Beauty (ULTA.US)$ disgusting awful abysmal garbage
$Ulta Beauty (ULTA.US)$ i can’t believe I wasted time on this stock
$Ulta Beauty (ULTA.US)$ awful. absolutely awful.
$Ulta Beauty (ULTA.US)$ down 3 out of 4 days this week 🤣🤣🤣🤣 you can’t make this up
$Ulta Beauty (ULTA.US)$ awful stock
$Ulta Beauty (ULTA.US)$ did you listen? i hope you did. KNEEEEEEEL
$Ulta Beauty (ULTA.US)$ downnnnnn downnnn even if the sky is falling down
$Ulta Beauty (ULTA.US)$ down like Jay Sean.
No comment yet
Millaai : Are you being trapped and looking for a rescuer everywhere?
Growth Investor27 : Good info, NEXLIZET is a great drug, my brother takes it. ESPR stock is undervalued, should be above $5
Growth Investor27 Millaai : The author has been buying below $2 so your comment is off. This research article has all the due diligence to see, other than the fact Institutions have been heavly buying this year, fintel shows now 74% owned. ESPR is a good investment.
104248191 : please f o
Detached House Millaai : You are wrong. Though short term looks like the price is consolidating, the weekly chart looks promising! So look at the chart to see if it aligns with the fundamentals before criticising others!
View more comments...